Travere Therapeutics Inc
TVTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.29B
Close$
Share Statistics
| Market cap | $5.29 Billion |
|---|---|
| Enterprise Value | $5.79 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.06 |
| Outstanding Shares | 93,479,416 |
Return
| Return on Equity | -270.52% |
|---|---|
| Return on Assets | -8.30% |
| Return on Invested Capital | -10.32% |
Valuation & Multiples
| P/E Ratio | -126.51 |
|---|---|
| PEG | -73.21 |
| Price to Sales | 9.49 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 9.8 |
| Enterprise Value to EBIT | -86.68 |
| Enterprise Value to Net Income | -88 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 25.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$159.59 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$195.68 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6145▼ 10.37% |
|---|---|
| Total Calls | 1,283,500▼ 50.70% |
| Total Puts | 788,700▼ 57.82% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 113.51%▲ 3.16% |
|---|---|
| Total Invested | $6.03B▲ 100.11% |
| Investors Holding | 332▲ 52.00% |
ESG Score
No data